[{"address1": "7750 El Camino Real", "address2": "Suite 2A", "city": "Carlsbad", "state": "CA", "zip": "92009", "country": "United States", "phone": "858 704 4900", "website": "https://www.palisadebio.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on focuses on developing therapeutics that protect the integrity of the intestinal barrier in the United States. The company's lead therapeutic candidate is LB1148, an oral liquid formulation of the digestive enzyme inhibitor tranexamic acid to reduce the formation of postoperative adhesions, postoperative ileus, and return of bowel function in adults. It has a license agreement with the Regents of the University of California; and co-development and distribution agreement with Newsoara Biopharma Co., Ltd. Palisade Bio, Inc. is based in Carlsbad, California.", "fullTimeEmployees": 9, "companyOfficers": [{"maxAge": 1, "name": "Mr. J. D. Finley", "age": 65, "title": "CEO, CFO & Director", "yearBorn": 1958, "fiscalYear": 2023, "totalPay": 791333, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mitchell Lawrence Jones M.D., Ph.D.", "age": 45, "title": "COO & Chief Medical Officer", "yearBorn": 1978, "fiscalYear": 2023, "totalPay": 635002, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ryker  Willie", "title": "Senior VP of Finance & Corporate Controller", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 4.71, "open": 4.66, "dayLow": 4.66, "dayHigh": 5.0, "regularMarketPreviousClose": 4.71, "regularMarketOpen": 4.66, "regularMarketDayLow": 4.66, "regularMarketDayHigh": 5.0, "beta": 1.46, "forwardPE": -0.41603372, "volume": 28848, "regularMarketVolume": 28848, "averageVolume": 697460, "averageVolume10days": 3156460, "averageDailyVolume10Day": 3156460, "bid": 3.46, "ask": 6.09, "bidSize": 200, "askSize": 200, "marketCap": 4197407, "fiftyTwoWeekLow": 3.82, "fiftyTwoWeekHigh": 36.6, "priceToSalesTrailing12Months": 16.789627, "fiftyDayAverage": 5.7674, "twoHundredDayAverage": 10.68335, "currency": "USD", "enterpriseValue": -7863593, "floatShares": 836476, "sharesOutstanding": 851401, "sharesShort": 1828, "sharesShortPriorMonth": 5117, "sharesShortPreviousMonthDate": 1709164800, "dateShortInterest": 1711584000, "sharesPercentSharesOut": 0.0021, "heldPercentInsiders": 0.01753, "heldPercentInstitutions": 0.1552, "shortRatio": 0.16, "shortPercentOfFloat": 0.0025, "bookValue": 18.301, "priceToBook": 0.26938418, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -12316000, "trailingEps": -27.0, "forwardEps": -11.85, "lastSplitFactor": "1:6", "lastSplitDate": 1619568000, "enterpriseToRevenue": -31.454, "enterpriseToEbitda": 0.612, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "PALI", "underlyingSymbol": "PALI", "shortName": "Palisade Bio, Inc.", "longName": "Palisade Bio, Inc.", "firstTradeDateEpochUtc": 1175261400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "48a6a4f2-9a74-360b-918d-da0f22330672", "gmtOffSetMilliseconds": -14400000, "currentPrice": 4.93, "targetHighPrice": 45.0, "targetLowPrice": 22.5, "targetMeanPrice": 33.75, "targetMedianPrice": 33.75, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 2, "totalCash": 12432000, "totalCashPerShare": 14.602, "ebitda": -12841000, "totalDebt": 369000, "quickRatio": 4.865, "currentRatio": 5.154, "totalRevenue": 250000, "debtToEquity": 3.262, "revenuePerShare": 0.548, "returnOnAssets": -0.53853, "returnOnEquity": -1.03396, "freeCashflow": -6471500, "operatingCashflow": -11133000, "grossMargins": 1.0, "operatingMargins": -51.38, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-04-23"}]